Regeneron Pharmaceuticals
REGN
REGN
1,197 hedge funds and large institutions have $46.9B invested in Regeneron Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 133 funds opening new positions, 440 increasing their positions, 475 reducing their positions, and 203 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
20% less capital invested
Capital invested by funds: $58.4B → $46.9B (-$11.5B)
20% less funds holding in top 10
Funds holding in top 10: 15 → 12 (-3)
34% less first-time investments, than exits
New positions opened: 133 | Existing positions closed: 203
Holders
1,197
Holding in Top 10
12
Calls
$1.15B
Puts
$1.01B
Top Buyers
| 1 | +$789M | |
| 2 | +$318M | |
| 3 | +$202M | |
| 4 |
BlackRock
New York
|
+$184M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$171M |
Top Sellers
| 1 | -$2.24B | |
| 2 | -$902M | |
| 3 | -$740M | |
| 4 |
Capital International Investors
Los Angeles,
California
|
-$433M |
| 5 |
Amundi
Paris,
France
|
-$387M |
